Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2017 - 09 - 28

Carabinieri’s csi department has new technology for fighting crime

100% Italian technology and fruit of Menarini’s research on tumour diagnosis for the identification of criminal offenders in cases like murder, sexual assault, robbery...


A new application for technology used in medicine has been discovered thanks to the collaboration between RIS (Reparto Investigazioni Scientifiche - Crime Scene Investigation Department) of the Carabinieri (Italian police) of Rome and Menarini. Destined to change the world of forensic science, this new technology application has even been published in the journal “Forensic Science International.”


Biological evidence found at the crime scene is often composed of different types of biological material of two or more people. The analysis of these mixed genetic traces presents a problem in forensics because it does not always produce a unique DNA profile and this makes the identification of the offender more difficult, requiring the use of complex statistical analyses.

Thanks to DEPArray, automated technology for the identification and isolation of pure cells, researchers have for the first time been able to separate cells belonging to different biological fluids (e.g. blood, saliva, semen) before carrying out the standard genetic analysis, and can therefore obtain a pure and corresponding genetic profile.


RIS and Menarini began their long project by analysing biological mixtures created at random: a mixture of liquids reproduced in the laboratory that contained blood, saliva and semen. The results of these analyses were surprising: in 100% of cases, DEPArray managed to identify the fluids and the corresponding genetic profile.


It was then possible to analyse real samples from a case of sexual assault. The analysis of these samples allowed for the identification of the type of cells (sperm cells) and therefore of the offender’s profile, confirming that the developed approach could be used successfully on real biological traces, not just simulated ones.

Obviously, being the first of its kind, further tests are necessary on a large number of real samples. With this in mind, Menarini Silicon Biosystems will continue its collaboration with Rome’s RIS Carabinieri and other forensic laboratories abroad for the experimental corroboration of the protocol.



“The DEPArray project, developed by Menarini in collaboration with the RIS in Rome,” explained Lieutenant Colonel Andrea Berti, Commander of the Biological Division of the Department - “is without a doubt the most promising and revolutionary piece of technology that the world of forensics has seen in recent years. For the first time, single cells (from donors) have in fact been physically separated from a biological mixture. This is an extraordinary result if we consider the analysis of biological traces that can be gleaned from evidence gathered during the course of an investigation. We will continue to work intensely on the project in order to fully understand the limits of this technology, then apply it to infinitely smaller traces that are found at the crime scene, and ultimately provide our investigations with another supporting instrument.”

“We are extremely pleased with the results of the collaboration between Menarini and the RIS Carabinieri,” - said Domenico Simone, Member of the Menarini Board of Directors - “DEPArray was studied and created by Italian researchers with the goal of diagnosing tumours from extremely small biopsies by actually using a simple blood sample. Today we are proud to know that we can also effectively contribute to other scientific areas in collaboration with the extraordinary abilities of the RIS Carabinieri.